Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Lymphoid 1

Conditions

Breast Neoplasms 5Pain, Postoperative 4Prostatic Neoplasms 3Postoperative Hemorrhage 2Neoplasms 2Kidney Neoplasms 2Delirium 2Central Nervous System Diseases 2Brain Neoplasms 2Thyroid Neoplasms 1Thromboembolism 1Surgical Wound Infection 1Spondylitis, Ankylosing 1Sleep Deprivation 1Skin Neoplasms 1Skin Diseases 1Seroma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Postoperative Shivering 1Pleural Effusion, Malignant 1Pituitary Neoplasms 1Pituitary Diseases 1Ovarian Neoplasms 1Neuroinflammatory Diseases 1Neurocognitive Disorders 1Neoplasms, Fibrous Tissue 1Neoplasms, Connective and Soft Tissue 1Neoplasms, Connective Tissue 1Neoplasms by Site 1Neoplasms by Histologic Type 1

Interventions

Vincristine 20Cytarabine 19Methotrexate 18Dexamethasone 17Cyclophosphamide 17Mercaptopurine 16Daunorubicin 12Asparaginase 12Doxorubicin 10Prednisolone 9Granulocyte Colony-Stimulating Factor 8Idarubicin 7Etoposide 7Thioguanine 6Teniposide 6Rituximab 6Prednisone 6Vindesine 5Ifosfamide 5Stem Cell Transplantation 4fludarabine 3Mitoxantrone 3Hydrocortisone 3pegaspargase 2Ketamine 2Inotuzumab Ozogamicin 2Imatinib Mesylate 2Cladribine 2Cholecalciferol 2pegylated granulocyte colony-stimulating factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 4 × Precursor Cell Lymphoblastic Leukemia-Lymphoma × Sodium Chloride × Clear all
NCT05176119 2022-01-04

Nalbuphine Versus Ketamine for Prevention of Emergence Agitation After Sevoflurane in Children Undergoing Tonsillectomy

Ain Shams University

Phase 4 Completed
90 enrolled
LymphoidOther hematologic neoplasm

Emergence Delirium, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡